Cover Image
市場調查報告書

北美人工皮(皮膚替代品)市場預測

North America Tissue Engineered - Skin Substitutes Market Outlook to 2020

出版商 GlobalData 商品編碼 315204
出版日期 內容資訊 英文 123 Pages
訂單完成後即時交付
價格
Back to Top
北美人工皮(皮膚替代品)市場預測 North America Tissue Engineered - Skin Substitutes Market Outlook to 2020
出版日期: 2014年10月31日 內容資訊: 英文 123 Pages
簡介

本報告提供北美人工皮(皮膚替代品)市場相關調查分析,提供您各市場區隔的市場規模資料,年度的市場收益·數量·平均銷售價格,企業佔有率·流通佔有率資料,主要企業簡介等相關的系統性資訊。

第1章 目錄

第2章 簡介

第3章 北美人工皮(皮膚替代品)市場

  • 人工皮(皮膚替代品)市場,北美,收益($m)
  • 人工皮(皮膚替代品)市場,北美,各收益的類別比較($m)
  • 人工皮(皮膚替代品)市場,北美,收益實際成果($m)
  • 人工皮(皮膚替代品)市場,北美,收益預測($m)
  • 人工皮(皮膚替代品)市場,北美,數量
  • 人工皮(皮膚替代品)市場,北美,數量實際成果
  • 人工皮(皮膚替代品)市場,北美,數量預測
  • 人工皮(皮膚替代品)市場,北美,各收益的企業佔有率($m)

第4章 加拿大的人工皮(皮膚替代品)市場

  • 人工皮(皮膚替代品)市場,加拿大,收益實際成果($m)
  • 人工皮(皮膚替代品)市場,加拿大,收益預測($m)
  • 人工皮(皮膚替代品)市場,加拿大,數量實際成果
  • 人工皮(皮膚替代品)市場,加拿大,數量預測
  • 人工皮(皮膚替代品)市場,加拿大,平均銷售價格($)
  • 人工皮(皮膚替代品)市場,加拿大,各收益的流通佔有率($m)
  • 人工皮(皮膚替代品)市場,加拿大,各收益的企業佔有率($m)

第5章 墨西哥的人工皮(皮膚替代品)市場

  • 人工皮(皮膚替代品)市場,墨西哥,收益實際成果($m)
  • 人工皮(皮膚替代品)市場,墨西哥,收益預測($m)
  • 人工皮(皮膚替代品)市場,墨西哥,數量實際成果
  • 人工皮(皮膚替代品)市場,墨西哥,數量預測
  • 人工皮(皮膚替代品)市場,墨西哥,平均銷售價格($)
  • 人工皮(皮膚替代品)市場,墨西哥,各收益的流通佔有率($m)
  • 人工皮(皮膚替代品)市場,墨西哥,各收益的企業佔有率($m)

第6章 美國的人工皮(皮膚替代品)市場

  • 人工皮(皮膚替代品)市場,美國,收益實際成果($m)
  • 人工皮(皮膚替代品)市場,美國,收益預測($m)
  • 人工皮(皮膚替代品)市場,美國,數量實際成果
  • 人工皮(皮膚替代品)市場,美國,數量預測
  • 人工皮(皮膚替代品)市場,美國,平均銷售價格($)
  • 人工皮(皮膚替代品)市場,美國,各收益的流通佔有率($m)
  • 人工皮(皮膚替代品)市場,美國,各收益的企業佔有率($m)

第7章 北美主要企業概要,人工皮(皮膚替代品)市場

  • Organogenesis, Inc.
  • Shire Plc
  • Kinetic Concepts, Inc.
  • Integra LifeSciences Holdings Corporation
  • Smith & Nephew Plc
  • Covidien plc
  • Molnlycke Health Care AB
  • BSN medical GmbH

第8章 附錄

圖表

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: GDMECR0232DB

GlobalData's new report, "North America Tissue Engineered - Skin Substitutes Market Outlook to 2020", provides key market data on the North America Tissue Engineered - Skin Substitutes market. The report provides value, in millions of US dollars, volume (in units) and average prices (in US dollars) within market segments - Synthetic Skin Substitutes, Biosynthetic Skin Substitutes and Biologic Skin Substitutes (Allograft (Cellular and Acellular) and Xenograft Acellular).

The report also provides company shares and distribution shares data for each of these market categories, and global corporate-level profiles of the key market participants, pipeline products, and news and deals related to the Tissue Engineered - Skin Substitutes market wherever available.

The data in the report is derived from dynamic market forecast models. GlobalData uses epidemiology and capital equipment-based models to estimate and forecast the market size. The objective is to provide information that represents the most up-to-date data of the industry possible.

The epidemiology-based forecasting model makes use of epidemiology data gathered from research publications and primary interviews with physicians to establish the target patient population and treatment flow patterns for individual diseases and therapies. Using prevalence and incidence data and diagnosed and treated population, the epidemiology-based forecasting model arrives at the final numbers.

Capital equipment-based forecasting models are done based on the installed base, replacements and new sales of a specific device/equipment in healthcare facilities such as hospitals, clinics and diagnostic centers. Data for average number of units per facility is used to arrive at the installed base of the capital equipment. Sales for a particular year are arrived at by calculating the replacement units and new units (additional and first-time purchases).

Extensive interviews are conducted with key opinion leaders (KOLs), physicians and industry experts to validate the market size, company share and distribution share data and analysis.

Scope

  • Market size data for Tissue Engineered - Skin Substitutes market segments - Synthetic Skin Substitutes, Biosynthetic Skin Substitutes and Biologic Skin Substitutes.
  • Annualized market revenues (USD million), volume (units) and average prices (in US dollars) data for each of the market segments. Data is provided from 2005 to 2013 and forecast to 2020.
  • 2013 company shares and distribution shares data for Tissue Engineered - Skin Substitutes market.
  • Global corporate-level profiles of key companies operating within the North America Tissue Engineered - Skin Substitutes.
  • Key players covered include Organogenesis, Inc, Kinetic Concepts, Inc. , Shire Plc and Smith & Nephew Plc.

Reasons to buy

  • Develop business strategies by identifying the key market categories and segments poised for strong growth in the future.
  • Develop market-entry and market expansion strategies.
  • Design competition strategies by identifying who-stands-where in the market.
  • Develop investment strategies by identifying the key market segments expected to register strong growth in the near future.
  • What are the key distribution channels and what's the most preferred mode of product distribution - Identify, understand and capitalize.

Table of Contents

1. Table of Contents

  • 1.1. List of Tables
  • 1.2. List of Figures

2. Introduction

  • 2.1. What Is This Report About
  • 2.2. Tissue Engineered - Skin Substitutes Market Segmentation
  • 2.3. Definitions of Markets Covered in the Report

3. Tissue Engineered - Skin Substitutes Market, North America

  • 3.1. Tissue Engineered - Skin Substitutes Market, North America, Revenue ($m), 2005-2020
  • 3.2. Tissue Engineered - Skin Substitutes Market, North America, Category Comparison by Revenue ($m), 2005-2020
  • 3.3. Tissue Engineered - Skin Substitutes Market, North America, Revenue ($m), 2005-2013
  • 3.4. Tissue Engineered - Skin Substitutes Market, North America, Revenue ($m), 2013-2020
  • 3.5. Tissue Engineered - Skin Substitutes Market, North America, Volume (Units), 2005-2020
  • 3.6. Tissue Engineered - Skin Substitutes Market, North America, Volume (Units), 2005-2013
  • 3.7. Tissue Engineered - Skin Substitutes Market, North America, Volume (Units), 2013-2020
  • 3.8. Tissue Engineered - Skin Substitutes Market, North America, Company Share by Revenue ($m), 2012-2013

4. Tissue Engineered - Skin Substitutes Market, Canada

  • 4.1. Tissue Engineered - Skin Substitutes Market, Canada, Revenue ($m), 2005-2013
  • 4.2. Tissue Engineered - Skin Substitutes Market, Canada, Revenue ($m), 2013-2020
    • 4.2.1. Biologic Skin Substitutes Market, Canada, Revenue ($m), by Segment, 2005-2013
      • 4.2.1.1. Allograft Market, Canada, Revenue ($m), by Sub Segment, 2005-2013
    • 4.2.2. Biologic Skin Substitutes Market, Canada, Revenue ($m), by Segment, 2013-2020
      • 4.2.2.1. Allograft Market, Canada, Revenue ($m), by Sub Segment, 2013-2020
  • 4.3. Tissue Engineered - Skin Substitutes Market, Canada, Volume (Units), 2005-2013
  • 4.4. Tissue Engineered - Skin Substitutes Market, Canada, Volume (Units), 2013-2020
    • 4.4.1. Biologic Skin Substitutes Market, Canada, Volume (Units), by Segment, 2005-2013
      • 4.4.1.1. Allograft Market, Canada, Volume (Units), by Sub Segment, 2005-2013
    • 4.4.2. Biologic Skin Substitutes Market, Canada, Volume (Units), by Segment, 2013-2020
      • 4.4.2.1. Allograft Market, Canada, Volume (Units), by Sub Segment, 2013-2020
  • 4.5. Tissue Engineered - Skin Substitutes Market, Canada, Average Price ($), 2005-2020
  • 4.6. Tissue Engineered - Skin Substitutes Market, Canada, Distribution Share by Revenue ($m), 2012-2013
  • 4.7. Tissue Engineered - Skin Substitutes Market, Canada, Company Share by Revenue ($m), 2012-2013

5. Tissue Engineered - Skin Substitutes Market, Mexico

  • 5.1. Tissue Engineered - Skin Substitutes Market, Mexico, Revenue ($m), 2005-2013
  • 5.2. Tissue Engineered - Skin Substitutes Market, Mexico, Revenue ($m), 2013-2020
    • 5.2.1. Biologic Skin Substitutes Market, Mexico, Revenue ($m), by Segment, 2005-2013
      • 5.2.1.1. Allograft Market, Mexico, Revenue ($m), by Sub Segment, 2005-2013
    • 5.2.2. Biologic Skin Substitutes Market, Mexico, Revenue ($m), by Segment, 2013-2020
      • 5.2.2.1. Allograft Market, Mexico, Revenue ($m), by Sub Segment, 2013-2020
  • 5.3. Tissue Engineered - Skin Substitutes Market, Mexico, Volume (Units), 2005-2013
  • 5.4. Tissue Engineered - Skin Substitutes Market, Mexico, Volume (Units), 2013-2020
    • 5.4.1. Biologic Skin Substitutes Market, Mexico, Volume (Units), by Segment, 2005-2013
      • 5.4.1.1. Allograft Market, Mexico, Volume (Units), by Sub Segment, 2005-2013
    • 5.4.2. Biologic Skin Substitutes Market, Mexico, Volume (Units), by Segment, 2013-2020
      • 5.4.2.1. Allograft Market, Mexico, Volume (Units), by Sub Segment, 2013-2020
  • 5.5. Tissue Engineered - Skin Substitutes Market, Mexico, Average Price ($), 2005-2020
  • 5.6. Tissue Engineered - Skin Substitutes Market, Mexico, Distribution Share by Revenue ($m), 2012-2013
  • 5.7. Tissue Engineered - Skin Substitutes Market, Mexico, Company Share by Revenue ($m), 2012-2013

6. Tissue Engineered - Skin Substitutes Market, United States

  • 6.1. Tissue Engineered - Skin Substitutes Market, United States, Revenue ($m), 2005-2013
  • 6.2. Tissue Engineered - Skin Substitutes Market, United States, Revenue ($m), 2013-2020
    • 6.2.1. Biologic Skin Substitutes Market, United States, Revenue ($m), by Segment, 2005-2013
      • 6.2.1.1. Allograft Market, United States, Revenue ($m), by Sub Segment, 2005-2013
    • 6.2.2. Biologic Skin Substitutes Market, United States, Revenue ($m), by Segment, 2013-2020
      • 6.2.1.2. Allograft Market, United States, Revenue ($m), by Sub Segment, 2013-2020
  • 6.3. Tissue Engineered - Skin Substitutes Market, United States, Volume (Units), 2005-2013
  • 6.4. Tissue Engineered - Skin Substitutes Market, United States, Volume (Units), 2013-2020
    • 6.4.1. Biologic Skin Substitutes Market, United States, Volume (Units), by Segment, 2005-2013
      • 6.4.1.1. Allograft Market, United States, Volume (Units), by Sub Segment, 2005-2013
    • 6.4.2. Biologic Skin Substitutes Market, United States, Volume (Units), by Segment, 2013-2020
      • 6.4.1.2. Allograft Market, United States, Volume (Units), by Sub Segment, 2013-2020
  • 6.5. Tissue Engineered - Skin Substitutes Market, United States, Average Price ($), 2005-2020
  • 6.6. Tissue Engineered - Skin Substitutes Market, United States, Distribution Share by Revenue ($m), 2012-2013
  • 6.7. Tissue Engineered - Skin Substitutes Market, United States, Company Share by Revenue ($m), 2012-2013

7. Overview of Key Companies in North America Tissue Engineered - Skin Substitutes Market

  • 7.1. Organogenesis, Inc.
    • 7.1.1. Company Overview
  • 7.2. Shire Plc
    • 7.2.1. Company Overview
  • 7.3. Kinetic Concepts, Inc.
    • 7.3.1. Company Overview
  • 7.4. Integra LifeSciences Holdings Corporation
    • 7.4.1. Company Overview
  • 7.5. Smith & Nephew Plc
    • 7.5.1. Company Overview
  • 7.6. Covidien plc
    • 7.6.1. Company Overview
  • 7.7. Molnlycke Health Care AB
    • 7.7.1. Company Overview
  • 7.8. BSN medical GmbH
    • 7.8.1. Company Overview

8. Appendix

  • 8.1. Research Methodology
    • 8.1.1. Coverage
    • 8.1.2. Secondary Research
    • 8.1.3. Primary Research
    • 8.1.4. Market Modeling and Forecasting
    • 8.1.5. Company Share Analysis
    • 8.1.6. Distribution Share Analysis
  • 8.2. Expert Panel
  • 8.3. GlobalData Consulting
  • 8.4. Contact Us
  • 8.5. Disclaimer

List of Tables

  • Table 1: Tissue Engineered - Skin Substitutes Market, Cross Country Comparison, North America, Revenue ($m), USD Constant, 2005-2020
  • Table 2: Tissue Engineered - Skin Substitutes Market, North America, Category Comparison by Revenue ($m), USD Constant, 2005-2020
  • Table 3: Tissue Engineered - Skin Substitutes Market, North America, Revenue ($m), Historic, USD Constant, 2005-2013
  • Table 4: Tissue Engineered - Skin Substitutes Market, North America, Revenue ($m), Forecast, USD Constant, 2013-2020
  • Table 5: Tissue Engineered - Skin Substitutes Market, North America, Volume (Units), 2005-2020
  • Table 6: Tissue Engineered - Skin Substitutes Market, North America, Volume (Units), Historic, 2005-2013
  • Table 7: Tissue Engineered - Skin Substitutes Market, North America, Volume (Units), Forecast, 2013-2020
  • Table 8: Tissue Engineered - Skin Substitutes Market, North America, Company Share by Revenue ($m), USD Constant, 2012-2013
  • Table 9: Tissue Engineered - Skin Substitutes Market, Canada, Revenue ($m), USD Constant, Historic, 2005-2013
  • Table 10: Tissue Engineered - Skin Substitutes Market, Canada, Revenue ($m), USD Constant, Forecast, 2013-2020
  • Table 11: Biologic Skin Substitutes Market, Canada, Revenue ($m), USD Constant, Historic, 2005-2013
  • Table 12: Allograft Market, Canada, Revenue ($m), USD Constant, Historic, 2005-2013
  • Table 13: Biologic Skin Substitutes Market, Canada, Revenue ($m), USD Constant, Forecast, 2013-2020
  • Table 14: Allograft Market, Canada, Revenue ($m), USD Constant, Forecast, 2013-2020
  • Table 15: Tissue Engineered - Skin Substitutes Market, Canada, Volume (Units), Historic, 2005-2013
  • Table 16: Tissue Engineered - Skin Substitutes Market, Canada, Volume (Units), Forecast, 2013-2020
  • Table 17: Biologic Skin Substitutes Market, Canada, Volume (Units), Historic, 2005-2013
  • Table 18: Allograft Market, Canada, Volume (Units), Historic, 2005-2013
  • Table 19: Biologic Skin Substitutes Market, Canada, Volume (Units), Forecast, 2013-2020
  • Table 20: Allograft Market, Canada, Volume (Units), Forecast, 2013-2020
  • Table 21: Tissue Engineered - Skin Substitutes Market, Canada, Average Price ($), Historic, 2005-2013
  • Table 22: Tissue Engineered - Skin Substitutes Market, Canada, Average Price ($), Forecast, 2013-2020
  • Table 23: Tissue Engineered - Skin Substitutes Market, Canada, Distribution Share by Revenue ($m), USD Constant, 2012-2013
  • Table 24: Tissue Engineered - Skin Substitutes Market, Canada, Company Share by Revenue ($m), USD Constant, 2012-2013
  • Table 25: Tissue Engineered - Skin Substitutes Market, Mexico, Revenue ($m), USD Constant, Historic, 2005-2013
  • Table 26: Tissue Engineered - Skin Substitutes Market, Mexico, Revenue ($m), USD Constant, Forecast, 2013-2020
  • Table 27: Biologic Skin Substitutes Market, Mexico, Revenue ($m), USD Constant, Historic, 2005-2013
  • Table 28: Allograft Market, Mexico, Revenue ($m), USD Constant, Historic, 2005-2013
  • Table 29: Biologic Skin Substitutes Market, Mexico, Revenue ($m), USD Constant, Forecast, 2013-2020
  • Table 30: Allograft Market, Mexico, Revenue ($m), USD Constant, Forecast, 2013-2020
  • Table 31: Tissue Engineered - Skin Substitutes Market, Mexico, Volume (Units), Historic, 2005-2013
  • Table 32: Tissue Engineered - Skin Substitutes Market, Mexico, Volume (Units), Forecast, 2013-2020
  • Table 33: Biologic Skin Substitutes Market, Mexico, Volume (Units), Historic, 2005-2013
  • Table 34: Allograft Market, Mexico, Volume (Units), Historic, 2005-2013
  • Table 35: Biologic Skin Substitutes Market, Mexico, Volume (Units), Forecast, 2013-2020
  • Table 36: Allograft Market, Mexico, Volume (Units), Forecast, 2013-2020
  • Table 37: Tissue Engineered - Skin Substitutes Market, Mexico, Average Price ($), Historic, 2005-2013
  • Table 38: Tissue Engineered - Skin Substitutes Market, Mexico, Average Price ($), Forecast, 2013-2020
  • Table 39: Tissue Engineered - Skin Substitutes Market, Mexico, Distribution Share by Revenue ($m), USD Constant, 2012-2013
  • Table 40: Tissue Engineered - Skin Substitutes Market, Mexico, Company Share by Revenue ($m), USD Constant, 2012-2013
  • Table 41: Tissue Engineered - Skin Substitutes Market, United States, Revenue ($m), USD Constant, Historic, 2005-2013
  • Table 42: Tissue Engineered - Skin Substitutes Market, United States, Revenue ($m), USD Constant, Forecast, 2013-2020
  • Table 43: Biologic Skin Substitutes Market, United States, Revenue ($m), USD Constant, Historic, 2005-2013
  • Table 44: Allograft Market, United States, Revenue ($m), USD Constant, Historic, 2005-2013
  • Table 45: Biologic Skin Substitutes Market, United States, Revenue ($m), USD Constant, Forecast, 2013-2020
  • Table 46: Allograft Market, United States, Revenue ($m), USD Constant, Forecast, 2013-2020
  • Table 47: Tissue Engineered - Skin Substitutes Market, United States, Volume (Units), Historic, 2005-2013
  • Table 48: Tissue Engineered - Skin Substitutes Market, United States, Volume (Units), Forecast, 2013-2020
  • Table 49: Biologic Skin Substitutes Market, United States, Volume (Units), Historic, 2005-2013
  • Table 50: Allograft Market, United States, Volume (Units), Historic, 2005-2013
  • Table 51: Biologic Skin Substitutes Market, United States, Volume (Units), Forecast, 2013-2020
  • Table 52: Allograft Market, United States, Volume (Units), Forecast, 2013-2020
  • Table 53: Tissue Engineered - Skin Substitutes Market, United States, Average Price ($), Historic, 2005-2013
  • Table 54: Tissue Engineered - Skin Substitutes Market, United States, Average Price ($), Forecast, 2013-2020
  • Table 55: Tissue Engineered - Skin Substitutes Market, United States, Distribution Share by Revenue ($m), USD Constant, 2012-2013
  • Table 56: Tissue Engineered - Skin Substitutes Market, United States, Company Share by Revenue ($m), USD Constant, 2012-2013
  • Table 57: Total Number of Primary Research Participants, Wound Care Management, by Country

List of Figures

  • Figure 1: Tissue Engineered - Skin Substitutes Market, Cross Country Comparison, North America, Revenue ($m), USD Constant, 2005-2020
  • Figure 2: Tissue Engineered - Skin Substitutes Market, North America, Category Comparison by Revenue ($m), USD Constant, 2005-2020
  • Figure 3: Tissue Engineered - Skin Substitutes Market, North America, Revenue ($m), Historic, USD Constant, 2005-2013
  • Figure 4: Tissue Engineered - Skin Substitutes Market, North America, Revenue ($m), Forecast, USD Constant, 2013-2020
  • Figure 5: Tissue Engineered - Skin Substitutes Market, North America, Volume (Units), 2005-2020
  • Figure 6: Tissue Engineered - Skin Substitutes Market, North America, Volume (Units), Historic, 2005-2013
  • Figure 7: Tissue Engineered - Skin Substitutes Market, North America, Volume (Units), Forecast, 2013-2020
  • Figure 8: Tissue Engineered - Skin Substitutes Market, North America, Company Share (%), 2013
  • Figure 9: Tissue Engineered - Skin Substitutes Market, Canada, Revenue ($m), USD Constant, Historic, 2005-2013
  • Figure 10: Tissue Engineered - Skin Substitutes Market, Canada, Revenue ($m), USD Constant, Forecast, 2013-2020
  • Figure 11: Biologic Skin Substitutes Market, Canada, Revenue ($m), USD Constant, Historic, 2005-2013
  • Figure 12: Allograft Market, Canada, Revenue ($m), USD Constant, Historic, 2005-2013
  • Figure 13: Biologic Skin Substitutes Market, Canada, Revenue ($m), USD Constant, Forecast, 2013-2020
  • Figure 14: Allograft Market, Canada, Revenue ($m), USD Constant, Forecast, 2013-2020
  • Figure 15: Tissue Engineered - Skin Substitutes Market, Canada, Volume (Units), Historic, 2005-2013
  • Figure 16: Tissue Engineered - Skin Substitutes Market, Canada, Volume (Units), Forecast, 2013-2020
  • Figure 17: Biologic Skin Substitutes Market, Canada, Volume (Units), Historic, 2005-2013
  • Figure 18: Allograft Market, Canada, Volume (Units), Historic, 2005-2013
  • Figure 19: Biologic Skin Substitutes Market, Canada, Volume (Units), Forecast, 2013-2020
  • Figure 20: Allograft Market, Canada, Volume (Units), Forecast, 2013-2020
  • Figure 21: Tissue Engineered - Skin Substitutes Market, Canada, Company Share (%), 2013
  • Figure 22: Tissue Engineered - Skin Substitutes Market, Mexico, Revenue ($m), USD Constant, Historic, 2005-2013
  • Figure 23: Tissue Engineered - Skin Substitutes Market, Mexico, Revenue ($m), USD Constant, Forecast, 2013-2020
  • Figure 24: Biologic Skin Substitutes Market, Mexico, Revenue ($m), USD Constant, Historic, 2005-2013
  • Figure 25: Allograft Market, Mexico, Revenue ($m), USD Constant, Historic, 2005-2013
  • Figure 26: Biologic Skin Substitutes Market, Mexico, Revenue ($m), USD Constant, Forecast, 2013-2020
  • Figure 27: Allograft Market, Mexico, Revenue ($m), USD Constant, Forecast, 2013-2020
  • Figure 28: Tissue Engineered - Skin Substitutes Market, Mexico, Volume (Units), Historic, 2005-2013
  • Figure 29: Tissue Engineered - Skin Substitutes Market, Mexico, Volume (Units), Forecast, 2013-2020
  • Figure 30: Biologic Skin Substitutes Market, Mexico, Volume (Units), Historic, 2005-2013
  • Figure 31: Allograft Market, Mexico, Volume (Units), Historic, 2005-2013
  • Figure 32: Biologic Skin Substitutes Market, Mexico, Volume (Units), Forecast, 2013-2020
  • Figure 33: Allograft Market, Mexico, Volume (Units), Forecast, 2013-2020
  • Figure 34: Tissue Engineered - Skin Substitutes Market, Mexico, Company Share (%), 2013
  • Figure 35: Tissue Engineered - Skin Substitutes Market, United States, Revenue ($m), USD Constant, Historic, 2005-2013
  • Figure 36: Tissue Engineered - Skin Substitutes Market, United States, Revenue ($m), USD Constant, Forecast, 2013-2020
  • Figure 37: Biologic Skin Substitutes Market, United States, Revenue ($m), USD Constant, Historic, 2005-2013
  • Figure 38: Allograft Market, United States, Revenue ($m), USD Constant, Historic, 2005-2013
  • Figure 39: Biologic Skin Substitutes Market, United States, Revenue ($m), USD Constant, Forecast, 2013-2020
  • Figure 40: Allograft Market, United States, Revenue ($m), USD Constant, Forecast, 2013-2020
  • Figure 41: Tissue Engineered - Skin Substitutes Market, United States, Volume (Units), Historic, 2005-2013
  • Figure 42: Tissue Engineered - Skin Substitutes Market, United States, Volume (Units), Forecast, 2013-2020
  • Figure 43: Biologic Skin Substitutes Market, United States, Volume (Units), Historic, 2005-2013
  • Figure 44: Allograft Market, United States, Volume (Units), Historic, 2005-2013
  • Figure 45: Biologic Skin Substitutes Market, United States, Volume (Units), Forecast, 2013-2020
  • Figure 46: Allograft Market, United States, Volume (Units), Forecast, 2013-2020
  • Figure 47: Tissue Engineered - Skin Substitutes Market, United States, Company Share (%), 2013
  • Figure 48: GlobalData Epidemiology-Based Forecasting Model
  • Figure 49: GlobalData Capital Equipment-Based Forecasting Model
  • Figure 50: Primary Interviews by Participant Type (%)
Back to Top